Videos

VIDEOS

High-Dose (HD) Tigecycline Therapy

PSMID 42nd Annual Convention Lectures

Industry-Sponsored Lecture (Philcare Pharma)

High-Dose (HD) Tigecycline Therapy: A Potent carbapenem-sparing weapon against MDROs (CRE/A. bau)

Speaker: Adrian Joseph L. Buensalido, MD, FPCP, FPSMID

Moderator: Jemelyn U. Garcia, MD, FPC, FPSMID

Cardiac, Renal & Pulmonary complications in COVID-19 patients (Experience in Management)

PSMID 42nd Annual Convention Lectures

Industry-Sponsored Lecture (Mylan)

Cardiac, Renal & Pulmonary complications in COVID-19 patients; expert experience in managing/recovery

Speakers:

Rontgene M. Solante, MD, FPCP, FPSMID

Aileen Wang, MD, FPCP, FPCCP

COVID and AMR: Antibiotic Use During COVID-19

PSMID 42nd Annual Convention Lectures

Industry-Sponsored Lecture (GSK)

COVID and AMR: Antibiotic Use During COVID-19 Pandemic and Implication for the Future

Speaker: Adrian Lijavetzki, MD

Clinical Advances in the management of HIV guidelines and New Evidence

PSMID 42nd Annual Convention Lectures

Industry-Sponsored Lecture (Camber)

Clinical Advances in the management of HIV guidelines and New Evidence

Speaker: Joseph Perriëns, MD, PhD
University of Ghent, Belgium

Understanding COVID-19: Testing and Optimizing Testing Strategies

PSMID 42nd Annual Convention Lectures

Industry-Sponsored Lecture (Roche)

Understanding COVID-19: Testing and Optimizing Testing Strategies

Speaker: Aw Tar Choon, MD

Clinicians Insights in the Management of Severe CAP, HAP and VAP

PSMID 42nd Annual Convention Lectures

Industry-Sponsored Lecture (Pfizer)

Clinicians insights in the Management of Severe CAP, HAP and VAP 

Speaker: Albert Rafanan, MD, FPCP, FPCCP

Reducing the Burden of Adult Influenza through a New Antiviral Treatment with a Novel Mechanism of Action

PSMID 42nd Annual Convention Lectures

Industry-Sponsored Lecture (Roche)

ONE AND DONE: Reducing the Burden of Adult Influenza through a New Antiviral Treatment with a Novel Mechanism of Action

Speaker: Dominic Dwyer, MD

Ceftaroline in Combating Community-Acquired Pneumonia

PSMID 42nd Annual Convention Lectures

Industry-Sponsored Lecture (Pfizer)

Ceftaroline in Combating Community-Acquired Pneumonia (CAP)

Speaker: Alex Soriano, MD

Head of Infectious Diseases Department, Hospital Clinic
Assistant Professor, University of Barcelona

Difference of SARS-CoV-2 and the new UK Strain Variant

Dr. Cynthia Saloma of the Philippine Genome Center explains the difference of SARS-CoV-2 and the new UK Strain Variant. (Source: Department of Health)